Compare ALV & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALV | ICLR |
|---|---|---|
| Founded | 1953 | 1990 |
| Country | Sweden | Ireland |
| Employees | 64100 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 8.2B |
| IPO Year | N/A | 2001 |
| Metric | ALV | ICLR |
|---|---|---|
| Price | $114.06 | $113.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $134.00 | ★ $178.62 |
| AVG Volume (30 Days) | 799.0K | ★ 1.1M |
| Earning Date | 04-17-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.10 | N/A |
| Revenue Next Year | $3.47 | N/A |
| P/E Ratio | $13.10 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $93.20 | $66.57 |
| 52 Week High | $130.14 | $211.00 |
| Indicator | ALV | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 52.27 |
| Support Level | $110.95 | $102.53 |
| Resistance Level | $128.82 | $114.75 |
| Average True Range (ATR) | 2.89 | 4.96 |
| MACD | 0.30 | -0.57 |
| Stochastic Oscillator | 32.18 | 57.19 |
Autoliv Inc is a developer, manufacturer, and supplier of passive safety systems to the automotive industry with a broad range of product offerings. Its product portfolio includes passive safety systems for commercial vehicles, battery cut-off switches, safety solutions for riders of motorcycles and bikes, airbags (including steering wheels and inflators), seatbelts, etc. Geographically, the group operates in the Americas, Europe, China, and Asia, excluding China, of which the maximum revenue is generated from its business in the Americas.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.